Skip to Content

IX 709 (Dexmethylphenidate hydrochloride extended-release 25 mg)

Pill with imprint IX 709 is Beige, Capsule-shape and has been identified as Dexmethylphenidate hydrochloride extended-release 25 mg. It is supplied by Impax Pharmaceuticals.

Dexmethylphenidate is used in the treatment of auditory processing disorder; adhd and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dexmethylphenidate 25 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for IX 709

Dexmethylphenidate hydrochloride extended-release

Imprint:
IX 709
Strength:
25 mg
Color:
Beige
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Labeler / Supplier:
Impax Pharmaceuticals
National Drug Code (NDC):
00115-1709

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide